The efficiency of electronic list-based multidisciplinary team meetings in management of gastrointestinal malignancy: a single-center experience in Southern China

Table 3 Short-term outcomes of all patients following various multidisciplinary approaches

	eMDT group (n = 2156)	cMDT group (n = 1518)	P value
Including Period	01/01/16–31/12/16	01/01/15–31/12/15
Accuracy in tumor staging^a, ratio(%)			0.070
Stage I	326/372 (87.6)	231/266 (86.8)	0.810
Stage II	699/854 (81.8)	386/555 (69.5)	< 0.001
Stage III	472/620 (76.1)	289/450 (64.2)	< 0.001
Stage IV	292/310 (94.2)	231/247 (93.5)	0.859
Overall LOS, days	12.0 ± 7.5	15.1 ± 10.4	< 0.001
Esophageal cancer	15.5 ± 6.8	18.7 ± 9.4	< 0.001
Gastric cancer	16.1 ± 8.4	20.3 ± 10.3	< 0.001
Colorectal cancer	10.4 ± 3.1	13.8 ± 8.3	< 0.001
Other malignancies	7.3 ± 10.2	8.6 ± 11.8	0.161
Overall LOPS, days^b	8.1 ± 7.2	10.8 ± 8.7	< 0.001
Esophageal cancer	10.2 ± 6.9	12.9 ± 7.2	0.003
Gastric cancer	11.5 ± 5.2	13.8 ± 6.9	< 0.001
Colorectal cancer	6.3 ± 4.1	9.8 ± 5.7	< 0.001
Other malignancies	6.1 ± 9.2	7.8 ± 9.3	0.031
Complications, n(%)	383 (17.6)	293 (19.3)	0.243
Bowel obstruction	206 (9.6)	147 (9.7)	0.910
SSI	125 (5.8)	90 (5.9)	0.887
IAH	28 (1.3)	26 (1.7)	0.331
Others^c	43 (2.0)	31 (2.0)	0.906
Unplanned reoperation, n(%)	21 (1.0)	16 (1.0)	0.867

LOS length of stay, LOPS length of postoperative stay, SSI surgical site infection, IAH intra-abdominal hemorrhage
^aPercentage of correct stage in clinical staging as the pathological stage
^bPatients receiving definitive operation were included for group comparison, with 1888 and 1336 cases in eMDT and cMDT groups respectively
^cOther complications include fever, pulmonary infection, deep vein thrombosis, urinary tract infection and so on. Data are expressed as number (%) or means ± SD, where appropriate

ISSN: 1477-7819